Parameters influencing the course of passive drug loading into lipid nanoemulsions
暂无分享,去创建一个
[1] Heike Bunjes,et al. Lipid nanoparticles for the delivery of poorly water‐soluble drugs , 2010, The Journal of pharmacy and pharmacology.
[2] M. Roller,et al. Mass Transport Phenomena in Lipid Oxidation and Antioxidation. , 2017, Annual review of food science and technology.
[3] Wei-Guo Dai,et al. Advanced screening assays to rapidly identify solubility-enhancing formulations: high-throughput, miniaturization and automation. , 2008, Advanced drug delivery reviews.
[4] Jochem Alsenz,et al. Miniaturized Assay for Solubility and Residual Solid Screening (SORESOS) in Early Drug Development , 2007, Pharmaceutical Research.
[5] F. Tiberg,et al. Drug delivery applications of non-lamellar liquid crystalline phases and nanoparticles , 2011 .
[6] H. Bunjes,et al. Drug release studies from lipid nanoparticles in physiological media by a new DSC method , 2017, Journal of controlled release : official journal of the Controlled Release Society.
[7] Tsuyoshi Murata,et al. {m , 1934, ACML.
[8] Heike Bunjes,et al. Lipid nanoparticles: drug localization is substance-specific and achievable load depends on the size and physical state of the particles. , 2014, Journal of controlled release : official journal of the Controlled Release Society.
[9] Alexander V. Kabanov,et al. Micelle formation and solubilization of fluorescent probes in poly(oxyethylene-b-oxypropylene-b-oxyethylene) solutions , 1995 .
[10] P. van Hoogevest,et al. Transfer of lipophilic drugs between liposomal membranes and biological interfaces: consequences for drug delivery. , 2005, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[11] S. Majumdar,et al. Injectable Lipid Emulsions—Advancements, Opportunities and Challenges , 2010, AAPS PharmSciTech.
[12] K. Mäder,et al. Solid lipid nanoparticles: production, characterization and applications. , 2001, Advanced drug delivery reviews.
[13] R. Müller,et al. SolEmuls-novel technology for the formulation of i.v. emulsions with poorly soluble drugs. , 2004, International journal of pharmaceutics.
[14] Peter Van Hoogevest,et al. Instant solubilization of poorly water-soluble drugs by in-situ loading of aqueous phospholipid dispersions suitable for parenteral administration. , 2006, PDA journal of pharmaceutical science and technology.
[15] L. Miller,et al. Modeling the influence of cyclodextrins on oral absorption of low‐solubility drugs: I. Model development , 2010, Biotechnology and bioengineering.
[16] L. S. Wan,et al. CMC of polysorbates. , 1974, Journal of pharmaceutical sciences.
[17] Manfred Kansy,et al. High throughput solubility measurement in drug discovery and development. , 2007, Advanced drug delivery reviews.
[18] B. Shekunov. Theoretical Analysis of Drug Dissolution in Micellar Media. , 2017, Journal of pharmaceutical sciences.
[19] P. Cullis,et al. Liposomal drug delivery systems: from concept to clinical applications. , 2013, Advanced drug delivery reviews.
[20] Control over Particle Size Distribution by Autoclaving Poloxamer-Stabilized Trimyristin Nanodispersions. , 2016, Molecular pharmaceutics.
[21] Paul D Leeson,et al. Molecular inflation, attrition and the rule of five. , 2016, Advanced drug delivery reviews.
[22] L. Miller,et al. Modeling the influence of cyclodextrins on oral absorption of low solubility drugs: II. Experimental validation , 2010, Biotechnology and bioengineering.
[23] Gordon L Amidon,et al. Dissolution and Solubility Behavior of Fenofibrate in Sodium Lauryl Sulfate Solutions , 2005, Drug development and industrial pharmacy.
[24] H. Bunjes,et al. Supercooled Smectic Nanoparticles: A Potential Novel Carrier System for Poorly Water Soluble Drugs , 2004, Pharmaceutical Research.
[25] Hywel D Williams,et al. Strategies to Address Low Drug Solubility in Discovery and Development , 2013, Pharmacological Reviews.
[26] Rebecca Lyn Carrier,et al. Predicting the Effect of Fed-State Intestinal Contents on Drug Dissolution , 2010, Pharmaceutical Research.
[27] Heike Bunjes,et al. Incorporation of the Model Drug Ubidecarenone into Solid Lipid Nanoparticles , 2001, Pharmaceutical Research.
[28] Heike Bunjes,et al. Evaluation of the drug loading capacity of different lipid nanoparticle dispersions by passive drug loading , 2017, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[29] Heike Bunjes,et al. Parenteral formulation of an antileishmanial drug candidate--tackling poor solubility, chemical instability, and polymorphism. , 2013, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[30] L. Deriemaeker,et al. Ostwald ripening and solubilization in alkane in water emulsions stabilized by different surfactantsPresented at the 17th Conference of the European Colloid & Interface Science Society, Firenze, Italy, September 21?26, 2003. , 2004 .
[31] Ingo Ott,et al. Alkynyl gold(I) phosphane complexes: Evaluation of structure-activity-relationships for the phosphane ligands, effects on key signaling proteins and preliminary in-vivo studies with a nanoformulated complex. , 2016, Journal of inorganic biochemistry.
[32] Heike Bunjes,et al. Crystallization tendency and polymorphic transitions in triglyceride nanoparticles , 1996 .